All In Biotech

Free tool

FAERS Monitor: Rocaltrol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021068 or its brand name (Rocaltrol, Calcitriol). Reports on generic versions are filed under their own applications.

Reports

20,257

Serious

15,687

77% of reports

Hospitalization

8,629

Death reported

2,692

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea1,470
  • diarrhoea1,194
  • off label use1,162
  • chronic kidney disease1,115
  • vomiting1,109
  • dyspnoea1,099
  • renal failure1,058
  • fatigue1,050
  • acute kidney injury973
  • death908
  • drug hypersensitivity882
  • drug ineffective801
  • abdominal pain789
  • headache768
  • asthenia766

Reports by year received

View as table
YearReports
2004179
2005245
2006171
2007190
2008282
2009388
2010392
2011400
2012513
2013525
2014541
2015863
20161,153
20171,378
20181,728
20192,327
20201,542
20211,449
20221,158
20231,212
20241,417
20251,212
2026992

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,033,902 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic kidney diseaseSignal1,11515.414.614,886
renal failureSignal1,0588.37.96,806
acute kidney injurySignal9736.66.24,658
drug hypersensitivitySignal8824.74.52,619
abdominal painSignal7893.53.31,439
vomitingSignal1,1092.52.3972
astheniaSignal7662.12.0458
dyspnoeaSignal1,0992.01.9578
nausea1,4701.91.8683
diarrhoea1,1941.91.8543
fatigue1,0501.41.3124
off label use1,1621.41.3125
headache7681.31.246
death9081.11.08
drug ineffective8010.60.6184

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.